Pregled bibliografske jedinice broj: 1200318
Prediction of unfractioned heparin effect using deep learning approach
Prediction of unfractioned heparin effect using deep learning approach // Eur J Anaesthesiol 2022 ; 39(Suppl 60):244
Milano, Italija, 2022. str. 244-244 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1200318 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Prediction of unfractioned heparin effect using deep
learning approach
Autori
Radocaj, Tomislav ; Lijovic, Lada ; Pazur, Iva ; Pelajic, Stipe ; Skrtic, Matteo ; Azdajic, Stjepan
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Eur J Anaesthesiol 2022 ; 39(Suppl 60):244
/ - , 2022, 244-244
Skup
Euroanaesthesia 2022
Mjesto i datum
Milano, Italija, 04.06.2022. - 06.06.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
anticoagulants ; Pharmacology ; dose-response ; Model ; statistical
Sažetak
Background and Goal of Study: Unfractioned heparin (UFH) is the anticoagulant of choice during carotid endarterectomy surgery (CEA). Activated partial thromboplastin time (aPTT) has been the primary laboratory test used to monitor effect of UFH. Range of 1.5-2.5 times baseline value has gained wide acceptance as therapeutic range in daily clinical practice. Despite being cornerstone of anticoagulation, UHF is limited by its unpredictable pharmacokinetic profile and is difficult to dose accurately. We hypothesized that deep learning, a type of machine learning based on a set of algorithms to model high level abstractions in data using multiple linear and nonlinear transformations, could better interpret the dose-response relationship of UFH. Materials and Methods: We studied 63 consecutive patients undergoing elective carotid endarterectomy in superficial cervical block. Heparin sodium 50 U/kg of total body weight was administered 3 minutes before application of carotid artery cross-clamp and aPTT was measured 30 minutes after heparin administration. We built a model for prediction of aPTT of 1.5 to 2.5 times the baseline value using artificial neural network (ANN). ANN was composed of three layers: input layer, the middle layer and output layer. Input variables included the pharmacokinetic-pharmacodynamic covariates (age, sex, weight, height, previous antiplatelet therapy, complete blood count, biochemistry panel, baseline coagulogram, total heparin dose). Twenty percent of the dataset was used as a testing dataset, and the remaining were used for model training. Results and Discussion: The activation function used for both ANN layers was sigmoid. aPTT of 1.5 to 2.5 times the baseline value at 30 minutes occurred in 12 patients (19.0%). The area under the receiving operator curve (AUROC) was 0.752 with deep learning algorithm prediction accuracy of 90.4%. None of the patients were bellow therapeutic range of aPTT. Conclusion(s): Deep learning approach can be used for calculating better dosage of used drugs to deliver safer, more efficient and more cost-effective doses. Adding more clinical data into this model and testing various models might further improve prediction of heparin effect.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Farmacija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
KBC "Sestre Milosrdnice"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE